Multidrug-resistant tuberculosis in patients with HIV infection in the CIS countries

Author(s):  
Zimina V.N. Zimina ◽  
Kravchenko A.V. Kravchenko ◽  
Kulabukhova E.I. Kulabukhova ◽  
Suvorova Z.K. Suvorova ◽  
Pokrovskaya А.V. Pokrovskaya ◽  
...  
2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Zeeba Zahra Sultana ◽  
Farhana Ul Hoque ◽  
Joseph Beyene ◽  
Md. Akhlak-Ul-Islam ◽  
Md Hasinur Rahman Khan ◽  
...  

An amendment to this paper has been published and can be accessed via the original article.


2021 ◽  
Vol 11 (5) ◽  
pp. 989-993
Author(s):  
A. V. Kukurika ◽  
E. I. Yourovskaya ◽  
V. A. Lyakhimets

The epidemiological significance of combined forms of especially dangerous infections has not been studied enough, unlike mono-infections. Currently, there is a tendency towards an increase in the incidence of multidrug-resistant tuberculosis. The formation of severe forms of the disease is caused by other widespread infections, such as chronic viral hepatitis and HIV. Polymorbid conditions distort the clinical manifestations of tuberculosis, reduce the effectiveness of anti-tuberculosis therapy and worsen the prognosis of the disease. Risk factors among patients in this category need analysis to carefully monitor patients and ensure infection control. Objective is to analyze the factors affecting the course of multidrug-resistant tuberculosis in HIV-infected patients with concomitant viral hepatitis. Materials and methods. Cases of the combined pathology of multiresistant tuberculosis, HIV infection and viral hepatitis with a dominant diagnosis of tuberculosis are analyzed. Results and discussion. The influence of the immunological status on the course of combined pathology was revealed. Since all the patients under study had clinical stage 4 of HIV infection, tuberculosis developed as an opportunistic infection. Severe immunosuppression (CD4 < 200 cells/ml) contributed to the progression of the generalized tuberculosis process. Long-term immunodeficiency was an unfavorable factor; in the overwhelming majority of cases, antiretroviral therapy was prescribed only after tuberculosis was detected. The dependence of the clinical form of tuberculosis on the level of CD4-lymphocytes was noted: isolated lesion of the chest organs prevailed in patients with a level of CD4-lymphocytes more than 200 cells/ml, generalization of TB process — with CD4 less than 200 cells/ml. Patients with miliary tuberculosis had a higher mortality rate compared to patients with other clinical forms, regardless of antiretroviral therapy. It was revealed that socially disoriented young people with viral hepatitis C prevailed in the structure of patients, the prevalence of which was due to the influence of aggravating factors, such as alcohol and drug abuse, and stay in prisons. Against the background of combined treatment, there was no significant effect of viral hepatitis on the course of polymorbid conditions and the effectiveness of the therapy.


MedAlliance ◽  
2020 ◽  
pp. 6-13

In the article, a review of foreign and Russian literature suggests that both multidrug-resistant tuberculosis spread and the HIV epidemic are factors maintaining the high tuberculosis burden worldwide and in the Russian Federation. The main transmission pathway for HIV-infection in the Russian Federation, as well as in other countries of Eastern Europe and Central Asia, is now attributed to heterosexual contact, which has surpassed the intravenous injection route of transmission. A rise in heterosexual risk of HIV transmission is accelerating epidemic progression amongst the general population, thereby contributing to a generalization of the epidemic process. The authors also provide an analytical review of publications related to risk factors for multidrug-resistant tuberculosis development in HIV-infected patients. It is found that such literature is limited in foreign countries, as well as in the Russian Federation. There is information about the general role of HIV infection in tuberculosis burden, but the influence of socio-demographic, epidemiological and clinical factors for multidrug-resistant tuberculosis development in people living with HIV is not sufficiently studied. Thus, there is a need for further studies designed to analyze the socio-demographic, epidemiological and clinical characteristics of patients with multidrug-resistant tuberculosis and HIV co-infection in comparison with those who are HIV-negative. Knowledge of the main risk factors for multidrug-resistant tuberculosis development in people living with HIV will allow selective and targeted use of resources to achieve effective outcomes in treatment of HIV/TB co-infected patients.


1995 ◽  
Vol 333 (14) ◽  
pp. 907-912 ◽  
Author(s):  
Edward E. Telzak ◽  
Kent Sepkowitz ◽  
Peter Alpert ◽  
Sharon Mannheimer ◽  
Franz Medard ◽  
...  

Author(s):  
Irina Chernokhaeva ◽  
Elena Ershova ◽  
Maria Pavlova ◽  
Anna Starshinova ◽  
Nadezhda Sapozhnikova

2014 ◽  
Vol 14 (1) ◽  
Author(s):  
Kyung Mo Yoo ◽  
Eun-Jeong Joo ◽  
Joon-Sup Yeom ◽  
Seoung-Wan Chae ◽  
Shin Yeoung Lee ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document